Leiner recapitalization
This article was originally published in The Tan Sheet
Executive Summary
Golden Gate Capital, along with Leiner majority stakeholder North Castle, will take a $265 mil. investment in the private label firm as part of a $650 recapitalization deal. Lead underwriter UBS will provide the remaining $385 through the purchase of junk bonds and senior notes. Leiner originally was put up for sale in February (1"The Tan Sheet" Feb. 23, 2004, p. 3)...
You may also be interested in...
Leiner Ownership Expected To Change Hands In Recapitalization Deal
North Castle Partners is reportedly in the second round of talks to sell its stake in Leiner Health Products to another private equity firm
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.